Pharmaceutical News

RSS

Antibiotic-resistant bacteria could soon be targeted with Alzheimer's drug

Dangerous antibiotic-resistant bacteria could soon be targeted with a drug initially developed to treat Alzheimer's disease.

12 Dec 2018

London-based startup launches 'thedrug.store' aiming to clean up CBD industry

"thedrug.store" is an online Cannabidiol (CBD) retailer launched by a London-based startup, providing a selection of quality brands to meet the growing demand for CBD products in the UK and mainland Europe.

12 Dec 2018

New collaborative partnership in quest of novel antibiotics

The Global Antibiotic Research and Development Partnership, Eisai Co., Ltd. and Takeda Pharmaceutical Company Limited have signed an agreement for GARDP to access and screen components of Eisai and Takeda's chemical libraries.

12 Dec 2018

FDA issues warning letter to Zhejiang Huahai Pharmaceutical involved in valsartan recall

The U.S. Food and Drug Administration today released a warning letter issued to Zhejiang Huahai Pharmaceutical Co. Ltd. (ZHP), in Linhai, Taizhou Zhejiang China, the manufacturer of the active pharmaceutical ingredient (API) found in valsartan that is the subject of an ongoing FDA investigation into probable cancer-causing impurities in certain commonly prescribed heart medicines.

12 Dec 2018

Incorrect prescribing warnings in electronic prescribing systems

Electronic prescribing is becoming widespread. All states allow it, some states require it, and many institutions now mandate electronic prescribing.

12 Dec 2018

Drug repositioning strategy identifies potential new treatments for epilepsy

Drug repositioning-- taking known drugs and identifying new applications for them--is an attractive concept for speeding up the process of bringing drugs to human testing for unmet medical needs.

11 Dec 2018

Dermatology providers show interest in recommending cannabinoids to patients

The cannabis plant and its derivatives have been used in medicinal treatments for millennia. With the recent legalization of medical marijuana in 33 states across the country, as well as Washington, D.C., several specialties are weighing the possibilities of integrating cannabinoids into patient therapies, including dermatology.

11 Dec 2018

Statins associated with low risk of side effects

The cholesterol-lowering drugs called statins have demonstrated substantial benefits in reducing the risk of heart attacks and strokes caused by blood clots (ischemic strokes) in at-risk patients.

10 Dec 2018

Ultrarestrictive opioid prescribing strategy linked with reduction in number of pills dispensed

An ultrarestrictive opioid prescribing strategy was associated with a reduction in the number of pills dispensed in a study of patients having surgery for gynecologic cancer, without changes in postoperative pain scores, complications or increases in prescription refill requests.

9 Dec 2018

International investigators fight against the negative campaign on benzodiazepines

In the current issue of Psychotherapy and Psychosomaticsthere is news about an international group of investigators who felt that benzodiazepines are getting unwarranted bad press, compared to other psychotropic drugs.

9 Dec 2018

Study: Drug reduces hot flash frequency, improves quality of life in breast cancer survivors

Research led by oncologists Roberto Leon-Ferre, M.D. and Charles Loprinzi, M.D. of Mayo Clinic has found that the drug oxybutynin helps to reduce the frequency and intensity of hot flashes in women who are unable to take hormone replacement therapy, including breast cancer survivors.

7 Dec 2018

High intensity statin treatment and adherence could save more lives

Thousands of heart attacks and deaths from cardiovascular disease could be prevented by patients taking higher doses of statins and taking the drugs as advised by doctors.

7 Dec 2018

VCU researchers test vaccine against opioid abuse

Virginia Commonwealth University researchers are testing a vaccine against opioid abuse developed by the Scripps Research Institute in California. The vaccine is meant to block the effects of heroin and fentanyl in patients with opioid use disorder.

7 Dec 2018

New study shows added benefit of ingenol mebutate for patients with actinic keratosis

Already in 2013, the German Institute for Quality and Efficiency in Health Care examined in an early benefit assessment whether ingenol mebutate offers greater benefit than the appropriate comparator therapy for patients with actinic keratosis.

7 Dec 2018

Deprescribing could help manage polypharmacy in older adults

Reducing the number of medications older adults use can have surprising benefits, according to research presented in a new issue of the journal Public Policy & Aging Report from The Gerontological Society of America.

6 Dec 2018

Statins are recommended far too often, study shows

Taking cholesterol-lowering drugs, or statins, as a preventive measure can reduce the risk of cardiovascular disease. A study by the University of Zurich now shows that this measure is recommended too often, as current guidelines fail to take into account the risks of side effects.

6 Dec 2018

CHOP celebrates EC approval of first and only gene therapy for patients with inherited retinal disease

Children's Hospital of Philadelphia celebrates a pivotal moment in medicine: approval by the European Commission of LUXTURNA (voretigene neparvovec), the first and only gene therapy for patients with an inherited retinal disease, last month.

6 Dec 2018

Heroin-assisted treatment can offer benefits, reduce harms

Providing supervised access to medical-grade heroin to people whose use continues after trying multiple traditional treatments has been successful in other countries, and should be piloted and studied in the United States, according to a new RAND Corporation study.

6 Dec 2018

Liraglutide drug associated with lower risk of cardiovascular events

Real world data from a large Nordic study shows that use of liraglutide, a drug for type 2 diabetes, is associated with a lower risk of myocardial infarction, stroke or cardiovascular death.

6 Dec 2018

Common antidepressant does not promote recovery after stroke, study finds

Stroke patients prescribed a common antidepressant show no improvement compared with those given a dummy drug, a study has found.

6 Dec 2018

Pharmaceutical News

Antibiotic-resistant bacteria could soon be targeted with Alzheimer's drug

London-based startup launches 'thedrug.store' aiming to clean up CBD industry

New collaborative partnership in quest of novel antibiotics

FDA issues warning letter to Zhejiang Huahai Pharmaceutical involved in valsartan recall

Incorrect prescribing warnings in electronic prescribing systems

Drug repositioning strategy identifies potential new treatments for epilepsy

Dermatology providers show interest in recommending cannabinoids to patients

Statins associated with low risk of side effects

Ultrarestrictive opioid prescribing strategy linked with reduction in number of pills dispensed

International investigators fight against the negative campaign on benzodiazepines

Study: Drug reduces hot flash frequency, improves quality of life in breast cancer survivors

High intensity statin treatment and adherence could save more lives

VCU researchers test vaccine against opioid abuse

New study shows added benefit of ingenol mebutate for patients with actinic keratosis

Deprescribing could help manage polypharmacy in older adults

Statins are recommended far too often, study shows

CHOP celebrates EC approval of first and only gene therapy for patients with inherited retinal disease

Heroin-assisted treatment can offer benefits, reduce harms

Liraglutide drug associated with lower risk of cardiovascular events

Common antidepressant does not promote recovery after stroke, study finds

Edoardo Fabini

Reducing polypharmacy through innovative drug formulation technologies

How innovation in dried blood spot testing is transforming neurological disease monitoring

Latest News